Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Lestuzzi

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
ESC Heart Failure|August 4, 2017
Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of CardiologyPatrizio Lancellotti, Maurizio Galderisi, Erwan Donal, et al.
Anticancer Research|October 2, 2019
Cardiovascular Risk Factors and Timing of Anthracyclines and Trastuzumab Cardiac ToxicityMaria Laura Canale, Andrea Camerini, Alda Huqi, et al.
Archives of Gerontology and Geriatrics|September 23, 2011
Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)Massimiliano Berretta, Ernesto Zanet, Guglielmo Nasti, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 10, 2013
Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patientsMassimiliano Berretta, Giuseppe Aprile, Guglielmo Nasti, et al.
The Oncologist|May 31, 2022
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical ExerciseChiara Lestuzzi, Davide Stolfo, Antonino De Paoli, et al.
Frontiers in Cardiovascular Medicine|July 5, 2021
Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) SurveyMaria Laura Canale, Fabio Turazza, Chiara Lestuzzi, et al.
Frontiers in Cardiovascular Medicine|May 27, 2022
Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) SurveyMaria Laura Canale, Fabio Turazza, Chiara Lestuzzi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2010
Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter studyChiara Lestuzzi, Alessandra Bearz, Christos Lafaras, et al.
Cancers|October 28, 2023
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue SarcomasAngela Buonadonna, Simona Scalone, Davide Lombardi, et al.
Giornale Italiano Di Cardiologia (2006)|September 27, 2021
[ANMCO Position paper: Cardio-oncology in the COVID-19 era]Irma Bisceglia, Domenico Gabrielli, Maria Laura Canale, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
ESC Heart Failure|August 4, 2017
Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of CardiologyPatrizio Lancellotti, Maurizio Galderisi, Erwan Donal, et al.
Anticancer Research|October 2, 2019
Cardiovascular Risk Factors and Timing of Anthracyclines and Trastuzumab Cardiac ToxicityMaria Laura Canale, Andrea Camerini, Alda Huqi, et al.
Archives of Gerontology and Geriatrics|September 23, 2011
Oxaliplatin-based chemotherapy in the treatment of elderly patients with metastatic colorectal cancer (CRC)Massimiliano Berretta, Ernesto Zanet, Guglielmo Nasti, et al.
Anti-Cancer Agents in Medicinal Chemistry|October 10, 2013
Oxaliplapin and capecitabine (XELOX) based chemotherapy in the treatment of metastatic colorectal cancer: the right choice in elderly patientsMassimiliano Berretta, Giuseppe Aprile, Guglielmo Nasti, et al.
The Oncologist|May 31, 2022
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical ExerciseChiara Lestuzzi, Davide Stolfo, Antonino De Paoli, et al.
Frontiers in Cardiovascular Medicine|July 5, 2021
Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) SurveyMaria Laura Canale, Fabio Turazza, Chiara Lestuzzi, et al.
Frontiers in Cardiovascular Medicine|May 27, 2022
Corrigendum: Portrait of Italian Cardio-Oncology: Results of a Nationwide Associazione Nazionale Medici Cardiologi Ospedalieri (ANMCO) SurveyMaria Laura Canale, Fabio Turazza, Chiara Lestuzzi, et al.
Lung Cancer (Amsterdam, Netherlands)|December 3, 2010
Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter studyChiara Lestuzzi, Alessandra Bearz, Christos Lafaras, et al.
Cancers|October 28, 2023
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue SarcomasAngela Buonadonna, Simona Scalone, Davide Lombardi, et al.
Giornale Italiano Di Cardiologia (2006)|September 27, 2021
[ANMCO Position paper: Cardio-oncology in the COVID-19 era]Irma Bisceglia, Domenico Gabrielli, Maria Laura Canale, et al.
Pageof 7